ProbioKid~® decreases the risks of common infection occurrences in children

摘要

At Vitafoods in Geneva Institut Rosell-Lallemand in partnership with Urgo, announced the results of a randomized, double-blind, placebo-controlled study conducted to evaluate the effects of key synbiotic ProbioKid~® (*distributed in France under the brand name Immunostim~®) on the incidence of infectious episodes in children during the winter period.rnThe study was conducted during the winter of 2006-2007 and involved 135 healthy, school-age children who had suffered from at least three episodes of ear-nose-throat (ENT), broncho-pulmonary or gastric disorder during the course of the previous winter. The study found that a three-month daily supplementation with ProbioKid~®* during the winter was able to reduce the risks of common infections in children.